Yahoo Finance

We launched Vision 2025 in the first quarter of 2017, and we are excited about our progress thus far, particularly in our two largest segments CCM and CIT that together account for approximately 90% of our total segment operating income. CCM status is a best-in-class building product supplier, continues to be exhibited through its price leadership, sustainable mid-single-digit organic growth supported by a multi-year commercial reroofing cycle and a margin profile we believe is sustainable. Carlisle Construction Materials continues to leverage its strong brand and its expansion throughout the building envelope, which could not be done without delivering the premium Carlisle experience that our contractors and distributor partners have come to rely on.

Looking back on CIT's history, we weathered a transition in technology with an in-flight entertainment solutions in 2017, but have come out of it well focused on driving the margins in excess of 20%. The team has restructured several operations over the past few years and is tracking well in its 2019 facility consolidation efforts. Our engineering expertise, brand, strong relationships with OEMs, an increased focus on a more profitable mix of business has elevated margins and we are solidly on pace to deliver mid-teens this year.

Our long-term tailwinds in aerospace build rates, coupled with our increasing content per plane is driving sustainable growth. We are in the early innings of building out a medical platform that has strong growth and profitability characteristics. Carlisle Medical Technologies is currently transitioning from a manufacturer of medical wire and cables to a turnkey supplier of medical devices to the world's leading OEMs. We continue to expand our capabilities around the design, development, and manufacturing of increasingly complex medical devices and components.

Turning to Fluid Technologies. We were attracted to this platform based on the market dynamics and profitability characteristics of the competitors in this space. We continue to believe CFT represents a long-term growth platform of 20% plus operating margins. We are still in the early stages of building out this platform, but are generating significant activity and results. While we have reached the end of our initial restructuring activities, we continue to drive efficiencies and are now focused on growth, both by increasing our R&D efforts and on acquisitions that broaden our product suite across several end markets, namely liquid and powder finishing, and sealants and adhesives. We're excited about the recent acquisitions we've made and I'll get into those a little later in the call.

Our free cash flow and strong balance sheet affords us both strategic and financial flexibility. When we introduced Vision 2025, we envisioned a balanced approach of organic growth investments, acquisitions and returning capital to shareholders. Over the last 2.5 years, we have -- we've been opportunistic and have repurchased close to $1 billion of shares, the total level we initially contemplated in our Vision 2025 plan. Going forward, our approach will remain balanced yet opportunistic with driving $15 of EPS by 2025 the key focus of our vision.

Now let me get into some specifics on our second quarter results. In the second quarter, we drove 6.4% revenue growth, totaling a record $1.3 billion of sales, our 25th consecutive quarter of year-over-year growth. We generated $207 million of operating income, a 30% increase over prior year, which led to record diluted EPS of $2.65, up 42% year-over-year, confirming that we are making the right investments, in our factories in our people and in the Carlisle Operating System.

Second quarter results were driven by strong execution, solid demand at CCM and CIT, price discipline across all four segments and efficiencies gained from COS. We continue to see a healthy backdrop in demand for both new construction and replacement products across the building envelope, while robust commercial aircraft build rates continue at CIT. Combined with price cost dynamics and efficiencies gained from prior year restructuring efforts, we leverage these positives into solid incremental margins.

Our restructuring and integration efforts at CCM, CIT and CBF are on track this year as evidenced by their second quarter margin improvements. And notably, at the beginning of 2019, we have projected $40 million to $50 million of price cost benefit at CCM in 2019, and I'm pleased that we have already achieved that milestone.

On the leadership front, we appointed Nick Shears to the role of President of CCM in May and appreciate the immediate and positive impact his leadership has brought to CCM during the last three quarters. Nick brings experience, skills and knowledge of the Carlisle executive team and we look forward to the contributions he will make as we execute Vision 2025.

Free cash flow in the second quarter was $70 million, leaving us with an ending cash position of $422 million, which in addition to our strong balance sheet and available $1 billion of untapped credit on our revolving facility, continues to afford us financial flexibility and strategic optionality. We continue to approach capital deployment in a balanced and disciplined manner, opportunistically buying back shares and seeking well-priced and strategic acquisitions.

In the second quarter, we continued our share repurchases, utilizing $75 million to buy 550,000 shares. We also paid $22.9 million in dividends. Since the beginning of 2017, we have returned approximately $1.2 billion to shareholders in the form of share repurchases and dividends. This clearly laid out in our M&A strategy under Vision 2025 in which we seek to deploy $3 billion. We were active in the second quarter in our core platforms of the building envelope, Medical Technologies and Fluid Technologies. We announced the acquisition of MicroConnex within CIT, Hosco integrated defense solutions, and Shinhang within CFT.

MicroConnex adds key sensor and micro-flex circuit technology to our Medical Technologies platform at CIT. We continue to pursue acquisitions to build out CIT's Medical Technologies capabilities to deliver a more complete set of integrated solutions to major medical OEMs. The Hosco IDS acquisition enabled us to leverage their innovative products for high viscosity dispensing and advanced fluid control and automotive aerospace and industrial markets. The acquisition of Shinhang, headquartered in South Korea complements Hosco ideas by adding strategic capabilities in Asia, expertise and technical diversity and sealing systems, pumps, spray guns and paints regulation systems. All three of these acquisitions come with strong brands built on years of excellent service to customers.

To add further capabilities to the CFT sealant and adhesives platform in July, we announced the acquisition of Ecco Finishing based in Sweden, a manufacturer of low and high pressure industrial painting equipment and sealing applicators. Ecco's innovative 3D sealing gun is well known and market-leading technology that will be a great addition to CFT's growing portfolio of sealants and adhesives application equipment.

We'd also like to note that Petersen Aluminum Corporation acquired earlier this year is sitting in very well within CCM's architectural metal platform and is an excellent complement to our 2017 and 2018 acquisitions of Drexel Metals, sunglass metal and premium panels, where sales, profitability and integration efforts are tracking to expectations.

Our M&A pipeline continues to be active and while asset prices are reflecting historically high levels, we are finding and executing solid bolt-on deals that make financial and strategic sense and create value for our shareholders.

Turning to Slide 4, we achieved record second quarter revenues of $1.3 billion, a 6.4% increase over 2018. This was driven by 2.3% organic growth, including 1.5% price realization and 4.7% from acquisitions with foreign exchange translation a headwind during the quarter.

Our operating income in the second quarter grew approximately 30% to $207 million, driving record second quarter diluted EPS of $2.65, which includes $0.06 of restructuring, facility rationalization and acquisition-related costs.

CCM revenues grew 10.4% year-over-year, close to 5% of net organic growth, reflecting continued strong underlying demand. 50% year-over-year growth from new product sales and the addition of Petersen Aluminum earlier in the year. We continue to see a solid backlog and sustained new construction demand in North America, and the expected flow of reroofing projects. This performance, yet again, demonstrates CCM's market leadership and resilience in the face of significantly wetter than average weather conditions experienced throughout the United States in the second quarter. With roofing labor markets remaining extremely tight, weather-related delays are adding to an already full backlog of contractors, leading us to believe the positive market dynamics will continue into 2020.

In addition to strong demand, the CCM business delivered excellent operating income growth, approximately 29% in the quarter, achieving 20% operating margins. This performance was driven by nearly $50 million [Phonetic] of price and roughly the same in raw material cost benefits. Notably, we accomplished this while maintaining share in the marketplace and facing weather-related headwinds in North America.

At CIT, revenue grew 3.2% in the second quarter, reflecting robust content growth at aerospace customers and continued progress in building our Medical Technologies platform. With the exception of the Boeing 737 MAX 8 and the issues that are very well known to the market, build rates remained strong across major aerospace models, providing a healthy backdrop for our largest platform within CIT.

Within Medical Technologies platform, we are excited about the MicroConnex acquisition announced early in the second quarter and are actively seeking acquisitions for further expansion of this platform. MicroConnex fits our well-established medical strategy and adds key sensor and micro flex technology to our Medical Technologies platform. When coupled with our 2018 acquisition of RedGroup, a Minneapolis-based provider of medical engineering solutions, MicroConnex further positioned CIT to participate earlier in the design and development activities at major medical OEMs.

CIT had strong operating leverage in the quarter, increasing margins 300 basis points year-over-year to 14.6%, which includes $2.4 million of investment in restructuring and acquisition costs.

CBF again had a difficult comparison in the second quarter to that of 2018 where as you may recall, sales increased over 17%. Demand across our key markets of construction and agriculture remain subdued relative to our expectations coming into 2019. As a result, CBF revenue declined 9.7% year-over-year. More importantly, in our view, CBF is seeing the benefits of a significant restructuring efforts around the closure of our Tulsa, Oklahoma manufacturing facility and integration into the Medina Ohio facility.

Despite pressured volumes, we are pleased that lower restructuring activity, price recovery and COS-driven efficiencies delivered 650 basis points of improvement in operating margin to 9.5%, in line with our expectations for margin improvement in 2019.

CFT -- CFT sales decline of 8.2% year-over-year was a reflection of difficult global automotive conditions, overall market dynamics in China and an impactful capital project delay with both automotive and industrial customers in North America. Despite these headwinds, CFT continues to progress on actions that align with the Vision 2025 plans, including maintaining price discipline, increasing R&D efforts and spend, and enhancing our breadth of product portfolio through new product launches and acquisitions.

CFT's operating margin was dramatically impacted by lower volumes, primarily from China and global automotive and Tier 1 accounts. We remain hopeful that the US China trade negotiations will make progress toward resolution in the near term, and there will be some decrease to the current level of uncertainty, that has delayed capital investment and spending.

Bob will now provide further detail about our second quarter financial performance and review our balance sheet and cash flow. Bob?

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Thank you, Chris. Please turn to the revenue bridge on Slide 5 of the presentation. As Chris mentioned earlier, we are pleased with our overall second quarter revenue performance. Organic growth was 2.3% in the quarter, driven by strong results in our non-residential roofing, commercial aero, and defense and space markets. Acquisitions contributed 4.7% of sales growth for the quarter and FX was a 60 basis point headwind.

Turning to our margin bridge on Slide 6. Q2 operating margin expanded 290 basis points. Positive pricing and volume leverage combined for 140 basis points of the year-over-year improvement. COS added 120 basis points. Freight, labor and raw material costs, netted to a 50 basis point improvement. And net restructuring and rationalization costs were an additional 40 basis point headwind partially offsetting these positives, acquisitions were a 60 basis point headwind.

On Slide 7, we have provided an EPS bridge. As Chris mentioned earlier, we reported record second quarter diluted EPS from continuing operations of $2.65, which compares to $1.87 last year. Positive volume price contributed $0.24 to the year-over-year increase. COS, which includes sourcing initiatives contributed $0.17. Raw material, freight and labor costs netted to a $0.13 benefit and a lower share count added an additional $0.15.

Now let's turn to Slide 8 to review the second quarter performance by segment in more detail. At CCM, revenues increased 10.4% with acquisitions contributing 6.1% of the growth and organic growth of 4.7%, partially offset by a 40 basis point foreign currency translation headwind. CCM executed extremely well in delivering approximately $30 million of net price cost realization in the quarter. Operating margin at CCM was 19.9% in the quarter, a 280 basis point improvement over last year. While the macro environment for commodity has helped us in the first half of the year, we are extremely pleased with CCM sourcing initiatives, which add to our confidence in sustaining the year-over-year margin improvement into the second half of 2019.

Now turn to Slide 9 to review CIT's results. CIT revenue grew 3.2% in the quarter. Aerospace remains a source of strength and main drivers of CIT positive results with medical, space and defense supportive [Phonetic] as well. We remain on plan with our product line rationalization efforts within medical, which while weighs on our topline near term benefits segment profitability. CIT's operating margins grew 300 basis points year-over-year to 14.6% given higher volumes, price realization, COS savings and sourcing.

And as I mentioned, benefits on product line exits predominantly within medical. These were partially offset by investment in restructuring projects, do right size and manufacturing footprint, wage inflation and acquisition-related costs.

Turning to Slide 10. CFT's organic revenue declined 11.7% year-over-year and FX was a 2.4% headwind in the second quarter. Despite market pressures, pricing was up 1.5% year-over-year, evidencing an appreciation for the value proposition for CFT's products. Additionally, acquisitions added 5.9% in the quarter. Operating margin declined 570 basis points year-over-year to 4.9%, as significant volume declines and related deleverage was partially offset by past restructuring and facility rationalization efforts, vertical integration savings and efficiencies from COS.

Turn now to Slide 11. CBS organic revenue decline of 7% was in line with our expectations due to the moderating growth in off-way highway vehicle markets and certain customers adjusting their inventory levels from significant growth in 2018. Successful price implementation and share gains during the quarter, partially offset the decline. FX also had a negative 2.7% impact. Operating income almost tripled to $8.3 million or 9.5% operating margin. We're very pleased, CBF was able to drive margin results in line with our expectations, despite the topline headwinds faced during the quarter.

On Slide 12, we show our balance sheet metrics. Balance sheet remains strong as we ended the quarter with $422 million of cash on hand and $1 billion of availability under our revolving credit line. During the quarter, we opportunistically repurchased $75 million of shares, bringing our year-to-date total to $232 million deployed on share repurchases.

Turn now to Slide 13. Our free cash flow was positive $69.6 million compared to a negative $60.4 million last year. The increase in free cash flow was primarily attributable to higher earnings, lower cash tax payments, more efficient use of working capital and lower CapEx.

And with that, I'll now turn the call back over to Chris.

D. Christian Koch -- President and Chief Executive Officer

Thanks, Bob. Please turn to Slide 14 as we discuss our updated 2019 outlook. For Carlisle, we continue to expect year-over-year growth to be in the high-single-digit range. By segment at CCM driven by what we view as a healthy North American non-residential construction market, the CCM team's price discipline, a solid backlog of worker contractors, tight labor markets and the addition of Petersen Aluminum, we continue to expect revenues to grow low double-digits in 2019. At CIT, we continue to expect revenue growth to increase mid-to-high single digits. We expect continued strength in our core CIT markets of aerospace and medical, and CIT continues to benefit from pricing actions taken in 2018 to offset inflation and other cost increases.

Our restructuring plans and related charges of $15 million remain on track, which is a reminder of related to the consolidation of North American facilities to drive operational improvements and efficiency gains. At CFT, we continue to expect revenue growth in the mid-single-digit range driven by the acquisitions of Hosco IDS, Shinhang and Ecco, strong price realization and new product introductions. At CBF, given the lower than expected volumes year-to-date, in part due to the robust sales volume levels last year and some softness in end markets resulting in adjustments to inventory levels at our customers, we now expect year-over-year revenues to decline mid-single digits.

Turning to our corporate items. Corporate expense is now expected to be approximately $95 million for the year. Depreciation and amortization expense is still expected to be approximately $200 million. For the full year, we expect capital expenditures of $110 million and free cash flow conversion above 110%. Net interest expense is currently expected to be approximately $58 million for the year and we now expect our tax rate to be approximately 23%.

As we pivot to the second half of 2019, we are well positioned to build on our record second quarter performance and continue the progress toward Vision 2025, and the goals of $8 billion in revenues, 20% operating income and 15% ROIC. We remain steadfast in our commitment to achieving our goals and driving to the $15 of earnings per share by 2025. We expect to deliver record performance in 2019 and we will continue to demonstrate excellent price discipline, focus on integration and restructuring efforts and to drive continuous improvement in all our operations.

I am extremely pleased that Carlisle employees around the globe embody an entrepreneurial spirit, are committed to excellence in all we do and are focused on delivering results for the Carlisle shareholders. This concludes our formal comments. Shantal, we are now ready for questions.

Questions and Answers:

Operator

[Operator Instructions] Your first question comes from Tim Wojs with Baird. Your line is open.

Tim Wojs -- Robert W. Baird & Co., Inc. -- Analyst

Hey, guys. Good afternoon. Nice Job.

D. Christian Koch -- President and Chief Executive Officer

Hi, Tim.

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Hi, Tim.

Tim Wojs -- Robert W. Baird & Co., Inc. -- Analyst

So I guess just a couple of questions on CCM. I guess Chris with you kind of getting to the kind of the 40 to -- I think you have $44 million or so of net price cost for the year, what's the right or maybe the updated way for us to think about that in the second half, both maybe from a price realization perspective and then a commodities perspective?

D. Christian Koch -- President and Chief Executive Officer

Yeah, I'll give you the overall and then Bob could break it up. I think we're going to be in the $60 million to $65 million range now for the full year. So that's up from that $40 million to $50 million projection we had earlier. And my guess is that price is going to build up $50 million of that. With -- yeah. But I'd say that $50 million on the upper end and maybe $10 million on the lower end.

Tim Wojs -- Robert W. Baird & Co., Inc. -- Analyst

Okay. Okay. So that would imply, probably in the fourth quarter, you may see a little bit of price slippage?

D. Christian Koch -- President and Chief Executive Officer

I would think, yeah, we might see some price slippages.

Tim Wojs -- Robert W. Baird & Co., Inc. -- Analyst

Okay. Okay, great. And then maybe bigger picture just on CCM from a volume perspective. Where do you think you're at in kind of the reroofing cycle on the commercial side? If you had to kind of -- I know it's hard to kind of triangulate, but do you think you're in kind of the second or third inning of the cycle or do you think you're kind of closer to the [Indecipherable]?

D. Christian Koch -- President and Chief Executive Officer

On the reroofing cycle, I think, I don't know that we have that graph that we produce, but in general, we started entering that reroofing say for the big reroofing cycle maybe five, six years ago and so I think if you think about this, it's not really an inning format though Tim because we believe that reroofing cycle will continue as we continue to put in new construction. But right now, I'd say over the short term, we're entering the sweet spot of the reroofing cycle.

Tim Wojs -- Robert W. Baird & Co., Inc. -- Analyst

Okay. Okay. And then I guess -- I guess lastly, just, this is more of a modeling question, but historically, I think the third quarter has been close to the second quarter in terms of absolute revenue dollars and just trying to understand that obviously was different last year due to some of the weather challenges in September. I'm just trying to understand if there is any reason why that historical relationship of maybe near parity from Q2 to Q3 shouldn't hold?

D. Christian Koch -- President and Chief Executive Officer

I would think there would be pretty much -- I would think we would see it playing out the same way we've seen it in the past, maybe a slight decline something in the low single digits maybe 1% or 2% difference between Q2 and Q3. The only caveat is that, last year that was such an -- there was such an impact from weather that obviously the year-over-year gains will be big, and with the strong backlog, we have and there might be some -- some upside to that.

Tim Wojs -- Robert W. Baird & Co., Inc. -- Analyst

Okay. Okay, great. I'll hop back in queue. Good luck on the second half, guys.

D. Christian Koch -- President and Chief Executive Officer

Thanks, Tim.

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Thanks, Tim.

Operator

Your next question comes from Bryan Blair with Oppenheimer. Your line is open.

Bryan Blair -- Oppenheimer & Co., Inc. -- Analyst

Good afternoon, guys. Great quarter in CCM.

D. Christian Koch -- President and Chief Executive Officer

Thank you.

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Hey, Bryan.

Bryan Blair -- Oppenheimer & Co., Inc. -- Analyst

So with mid-single-digit growth there, again against challenging stack comps obviously difficult to weather. I was wondering if you could quantify the impact of weather in the quarter, and more than offsetting that, how much growth either in dollar terms or percentage contribution to the quarter? You've gone from new products and also if you could parse out maybe product lines where you're likely taking share?

D. Christian Koch -- President and Chief Executive Officer

Yeah, I think the weather it is Bryan always hard to figure out what we lost. I think it's pretty similar to what we had in Q1. I'm going to say, somewhere between three and four days that amount in all and roofing days we take the aggregate across North America. And then on new products. I'll let Bob answer that question for you.

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Yeah, I mean we were up significantly, but it's a small base. Brian, we continue to grow that with the new glues, adhesives and membranes that we're putting out, but it's -- relative to the total, it's still a small number.

Bryan Blair -- Oppenheimer & Co., Inc. -- Analyst

Got it. Okay. And then in the slide, you call out that polyurethane platform profitability is improving. I think you had guided to mid-single-digit range for the year previously. Is there an update to that level of profitability?

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Yeah, yeah. And first of all, we're very excited about the new team that came in. And in the fourth quarter, we made all those changes, really got focused back on integrating the business into CCM, and we will exit the year at 10% and that will give us being on track for a model of exactly what we projected this year. So I'm really pleased with that team's delivering there.

Bryan Blair -- Oppenheimer & Co., Inc. -- Analyst

Yeah. Very good. And one more on CFT, if I can. You've maintained a mid-single-digit guide for the year relatively tough first half, particularly 2Q. Looking into the back half, how much are you baking into that guide for NPI contribution lift to organic there versus the M&A [Indecipherable]?

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Yeah. The new product introductions are going to -- they're going to start to roll out here end of September-October. But when you think about what's left in the year. I don't think there might be a little bit of stocking of those new units, but I don't think it will be of that impact. Well the bulk of this is going to be our acquisitions and obviously there'll be some organic declines in sales and I think they'll be close -- you didn't ask this, but they'll be close to probably what we experienced in the second quarter and what we're really looking for, obviously is to get some of this trade disagreement resolved, see the Chinese economy and especially the Chinese automotive market recover and help us out there.

Bryan Blair -- Oppenheimer & Co., Inc. -- Analyst

Okay, understood. All right. Thanks, again.

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

You bet.

Operator

Your next question comes from Kevin Hocevar with Northcoast Research. Your line is open.

Kevin Hocevar -- Northcoast Research -- Analyst

Hey, good evening, everybody, and a nice quarter.

D. Christian Koch -- President and Chief Executive Officer

Thanks, Kevin.

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Thanks.

Kevin Hocevar -- Northcoast Research -- Analyst

Wonder if you can comment on the backlog you're seeing in CCM. It sounds like weather has been a factor here in the first half of the year really, and it sounds like backlogs are really good and already good backlog got even better because some projects seem to be deferred. So if all the stars align here and we've just got sunny weather the rest of the year, what could volumes to be up here in the back half of the year based on what you're seeing and hearing from your customer base, and knowing that there seems to be labor has been an issue in terms of maybe capping the amount of growth that there can be, but what could growth look like here in the back half of the year, if we get some normal weather patterns?

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Yeah, Kevin, when we look back the gating factors labor at our contract, so the backlog is great. We think, if everything went well, and we had great weather 5% to 7% probably get up to 7% can happen in the marketplace on a volume basis.

Kevin Hocevar -- Northcoast Research -- Analyst

Got you. Okay and you mentioned to previous question about the price cost equation expecting some type of price slippage as we go through the year. Are you seeing anything right now or is there just an assumption in there that [Indecipherable] continue to trend down that eventually there is some type of slippage and given the backlogs and seemingly strong underlying demand, can that hold up better and maybe you hold price despite the raw materials coming down?

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Yeah, I mean, I -- we're assuming that it would be relatively flat. We don't think there'll be much slippage. Some of our competitors went out in the first half with price increases. Now that didn't drive a lot of change in behavior I'm going to call it. It did signal to the marketplace that the manufacturers are serious about maintaining price. So we're pretty comfortable that all the work we did late last year to get these price increases in should hold out for the rest of the year now.

Yeah, that can change quickly if something happens, but we're pretty confident that we can maintain at least close to -- I'm going to say when we got to the fourth quarter of last year we had them all baked in. So we would assume in the fourth quarter would, we'd be at least flat year-on-year price.

D. Christian Koch -- President and Chief Executive Officer

Yeah, Kevin, let me clarify that slippage. I should have done it for Tim. When I think about slippage, I was more thinking about the significant gains we had in Q1 and Q2 and then there was going to be slippage from that -- that and obviously we're lapping that pricing. And so we're not going to have that. So I don't -- I think Bob is exactly right that as we go into a three and four, I think we'll be relatively flat.

Kevin Hocevar -- Northcoast Research -- Analyst

Okay, that's good clarification, and then on the corporate expense, you were looking for $80 million as of last quarter, now it's up to $95 million, just kind of curious, has incentive comp gone up given the good results, or what's the reason for the increase in the corporate expense?

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Yeah, there is a couple of things. Some is the -- the share-based comp, we issued SARs last year with a nice run-up we had in the stock over the last quarter or two. That adds to it. We have been out in the marketplace, certainly doing a lot of work on acquisition, some of which we haven't closed on, that's about a third of it. And then incentive comp with the good results is higher than last year and higher than expected. And that's another third of it. So you take the increase. It's probably a third, a third, a third across those three things.

Kevin Hocevar -- Northcoast Research -- Analyst

Okay. Makes sense. All right. Thank you.

Operator

[Operator Instructions] Your next question comes from Garik Shmois with Longbow Research. Your line is open.

Garik Shmois -- Longbow Research -- Analyst

Hi, thanks and congratulations on the quarter. I wanted to ask on CFT margins. How we should think about that moving forward, just given the maybe temporarily challenged end market environment, plus the acquisitions that look like they're going to be a little bit dilutive to margins. So should this rate of margin compression that we saw in the second quarter be sustainable or and when should we start to see an acceleration of margin assuming you get some resolution?

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Yeah, I mean I think the compression, so we went from about what 10.6% last year down to about 5% this year. Now that included some acquisitions. So going into the third quarter, we would expect close to 450 basis point decline year-on-year and that's a lot. I mean, some of that's acquisitions, but a lot of that is just leverage on the volume. We do pretty good on our gross margin line. So we lose volume. It's -- It's tough.

And then as we get to the fourth quarter, we're expecting volumes to be up like they always are, but the compression in margin from the 14.6% last year would be down a little bit, but not as much as the second and third quarters because volume comes back.

Garik Shmois -- Longbow Research -- Analyst

Okay, that's helpful. And then any color just on CIT margins in the second half of the year, just given the acquisition that you're making. I guess a similar question, should we expect any -- any margin mix impact from the acquisitions and any update that you can have on the 737 MAX. I think last quarter you had called out maybe 100 basis points of headwinds. Is there any update to how that's been tracking?

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Yeah, I think on the margins on CIT probably a little bit lower in the third and fourth quarter. In the second quarter, we had some good mix and everything in the second quarter, but not down much more of the same at CIT for the third and fourth quarter. And then on the MAX, Boeing went from 52 a month to 42 a month earlier this year. We still haven't seen our orders to us to the subs going down at all. There is still filling up the supply chain getting ready to go back, continue to beef up production.

We're expecting that now that it pushed out to maybe the end of the year, next year, that's going to hit us soon and it's about $1 million a month if it does hit us. So for the rest of the year, it would be $5 million that we get it shortly.

Garik Shmois -- Longbow Research -- Analyst

Thank you.

Operator

Your next question comes from Neil Frohnapple with Buckingham Research. Your line is open.

Neil Frohnapple -- The Buckingham Research Group -- Analyst

Hey guys, congrats on a nice quarter. Just a quick follow-up on Fluid Technologies. Did you say what the acquisitions will contribute to revenue on a full year basis going forward?

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

$20 million full year.

D. Christian Koch -- President and Chief Executive Officer

That's second half.

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Second half. Sorry -- rest of this year.

Neil Frohnapple -- The Buckingham Research Group -- Analyst

$40 million in the second half. Okay. And then switching gears, can you talk more about the revenue outlook for break in friction. I mean is it your sense that underlying construction ag mining demand is deteriorating or are the revenue declines related more to temporary inventory rebalancing. Just any more color that would be helpful?

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Yeah, I think most of it for us was this heavy buying last year solid uptick and then we have added some of our biggest customers rebalancing. I think our outlook is pretty much in line with the OEs there. I think we've seen some struggling in North America due to the trade negotiations. Also the wet weather. So I don't really know, in some ways, if we have a super accurate demand going forward that would make a call either for something other than just what we've seen in the second quarter. So I think our anticipation as we look forward into Q3 and four is that we're going to see a lot of what we saw in Q1 and two.

Neil Frohnapple -- The Buckingham Research Group -- Analyst

Okay, great. Thanks so much. I'll pass it on.

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Great.

Operator

There are no further questions at this time, I'll now turn the call back over to the presenters.

D. Christian Koch -- President and Chief Executive Officer

Thanks, Shantal. This concludes our second quarter 2019 earnings call. Thanks everyone for your participation. We look forward to speaking with you at our next earnings call. Thank you.

Operator

This concludes today's call. You may now disconnect.

Duration: 39 minutes

Call participants:

Jim Giannakouros -- Vice President of Investor Relations and FP&A

D. Christian Koch -- President and Chief Executive Officer

Robert M. Roche -- Vice President, Chief Financial Officer and Investor Relations

Tim Wojs -- Robert W. Baird & Co., Inc. -- Analyst

Bryan Blair -- Oppenheimer & Co., Inc. -- Analyst

Kevin Hocevar -- Northcoast Research -- Analyst

Garik Shmois -- Longbow Research -- Analyst

Neil Frohnapple -- The Buckingham Research Group -- Analyst

More CSL analysis

All earnings call transcripts

More From The Motley Fool

• 10 Best Stocks to Buy Today

• The $16,728 Social Security Bonus You Cannot Afford to Miss

• 20 of the Top Stocks to Buy (Including the Two Every Investor Should Own)

• What Is an ETF?

• 5 Recession-Proof Stocks

• How to Beat the Market

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

Motley Fool Transcribers has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.